Order Article Reprints

Eklundh A, Rhedin S, Ryd-Rinder M, Andersson M, Gantelius J, Gaudenzi G, Lindh M, Peltola V, Waris M, Nauclér P, et al. Etiology of Clinical Community-Acquired Pneumonia in Swedish Children Aged 1–59 Months with High Pneumococcal Vaccine Coverage—The TREND Study. Vaccines. 2021; 9(4):384. https://doi.org/10.3390/vaccines9040384

Eklundh, Annika, Samuel Rhedin, Malin Ryd-Rinder, Maria Andersson, Jesper Gantelius, Giulia Gaudenzi, Magnus Lindh, Ville Peltola, Matti Waris, Pontus Nauclér, and et al. 2021. "Etiology of Clinical Community-Acquired Pneumonia in Swedish Children Aged 1–59 Months with High Pneumococcal Vaccine Coverage—The TREND Study" Vaccines 9, no. 4: 384. https://doi.org/10.3390/vaccines9040384

Eklundh, A., Rhedin, S., Ryd-Rinder, M., Andersson, M., Gantelius, J., Gaudenzi, G., Lindh, M., Peltola, V., Waris, M., Nauclér, P., Mårtensson, A., & Alfvén, T. (2021). Etiology of Clinical Community-Acquired Pneumonia in Swedish Children Aged 1–59 Months with High Pneumococcal Vaccine Coverage—The TREND Study. Vaccines, 9(4), 384. https://doi.org/10.3390/vaccines9040384